New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Infection Risk Increases With Longer Surgical Duration in Lower Extremity Bone Tumors

Infection Risk Increases With Longer Surgical Duration in Lower Extremity Bone Tumors

October 15, 2023Ryan ScottR. Lor Randall, MD discusses the primary results of the PARITY study and their implications for the use of antibiotics for patients with lower extremity bone tumors undergoin
World medicine November 23,2023
Infection Risk Increases With Longer Surgical Duration in Lower Extremity Bone Tumors

Infection Risk Increases With Longer Surgical Duration in Lower Extremity Bone Tumors

October 15, 2023Ryan ScottR. Lor Randall, MD discusses the primary results of the PARITY study and their implications for the use of antibiotics for patients with lower extremity bone tumors undergoin
World medicine November 23,2023
Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

In a recent review published in the journalCell, researchers discussed advancements in ribonucleic acid (RNA)-comprising lipid nanoparticle (LNP)-based immunotherapies for cancer and the improve
World medicine November 23,2023
Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

In a recent review published in the journalCell, researchers discussed advancements in ribonucleic acid (RNA)-comprising lipid nanoparticle (LNP)-based immunotherapies for cancer and the improve
World medicine November 23,2023
Dato-DXd Plus Durvalumab Elicits Durable Responses in Metastatic TNBC Regardless of PD-L1 Status

Dato-DXd Plus Durvalumab Elicits Durable Responses in Metastatic TNBC Regardless of PD-L1 Status

November 22, 2023Ryan ScottSupplements And Featured PublicationsUpdates in TROP2-Directed and Other Novel ADCs in Breast CancerVolume1Issue1Peter Schmid, FRCP, MD, PhD, discusses the evalu
World medicine November 23,2023
Dato-DXd Plus Durvalumab Elicits Durable Responses in Metastatic TNBC Regardless of PD-L1 Status

Dato-DXd Plus Durvalumab Elicits Durable Responses in Metastatic TNBC Regardless of PD-L1 Status

November 22, 2023Ryan ScottSupplements And Featured PublicationsUpdates in TROP2-Directed and Other Novel ADCs in Breast CancerVolume1Issue1Peter Schmid, FRCP, MD, PhD, discusses the evalu
World medicine November 23,2023
Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

August 31, 2023Caroline SeymourEmerging data continue to shape perioperative therapy decisions for patients with early-stage non–small cell lung cancer.Heather Wakelee, MDFindings from the phase 3 Che
World medicine November 23,2023
Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

August 31, 2023Caroline SeymourEmerging data continue to shape perioperative therapy decisions for patients with early-stage non–small cell lung cancer.Heather Wakelee, MDFindings from the phase 3 Che
World medicine November 23,2023
The Bleak Fiscal Implications of Advanced Cancer as a Chronic Illness

The Bleak Fiscal Implications of Advanced Cancer as a Chronic Illness

October 13, 2023Maurie Markman, MDMaurie Markman, MD, highlights the rather profound fiscal implications of the combined effect of 2 quite different but closely related components of the rapidly evolv
World medicine November 23,2023
The Bleak Fiscal Implications of Advanced Cancer as a Chronic Illness

The Bleak Fiscal Implications of Advanced Cancer as a Chronic Illness

October 13, 2023Maurie Markman, MDMaurie Markman, MD, highlights the rather profound fiscal implications of the combined effect of 2 quite different but closely related components of the rapidly evolv
World medicine November 23,2023
Global Colorectal Cancer Awareness Report Reveals Lack of Symptoms Holding Hungarians Back from Screening

Global Colorectal Cancer Awareness Report Reveals Lack of Symptoms Holding Hungarians Back from Screening

To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics released its State of Colorectal Cancer Awareness Report, marking the first-ever gl
World medicine November 23,2023
Global Colorectal Cancer Awareness Report Reveals Lack of Symptoms Holding Hungarians Back from Screening

Global Colorectal Cancer Awareness Report Reveals Lack of Symptoms Holding Hungarians Back from Screening

To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics released its State of Colorectal Cancer Awareness Report, marking the first-ever gl
World medicine November 23,2023
Window of Opportunity Trials Are Needed for Novel Tissue Biomarker Analysis in Head and Neck Cancers

Window of Opportunity Trials Are Needed for Novel Tissue Biomarker Analysis in Head and Neck Cancers

October 19, 2023Justine Yang Bruce, MDDeric L. Wheeler, PhDDrug development is a difficult and ever-changing process, with new agents being developed by industry and academic partners.Head and Neck Ca
World medicine November 23,2023
Window of Opportunity Trials Are Needed for Novel Tissue Biomarker Analysis in Head and Neck Cancers

Window of Opportunity Trials Are Needed for Novel Tissue Biomarker Analysis in Head and Neck Cancers

October 19, 2023Justine Yang Bruce, MDDeric L. Wheeler, PhDDrug development is a difficult and ever-changing process, with new agents being developed by industry and academic partners.Head and Neck Ca
World medicine November 23,2023
Shaping the Future of Cancer Care Through Student Training Health Collaborative

Shaping the Future of Cancer Care Through Student Training Health Collaborative

October 20, 2023Huntsman Cancer InstituteHuntsman Cancer Institute at the University of Utah and Utah Valley University proudly announce a groundbreaking partnership called the “Huntsman Cancer Instit
World medicine November 23,2023
Shaping the Future of Cancer Care Through Student Training Health Collaborative

Shaping the Future of Cancer Care Through Student Training Health Collaborative

October 20, 2023Huntsman Cancer InstituteHuntsman Cancer Institute at the University of Utah and Utah Valley University proudly announce a groundbreaking partnership called the “Huntsman Cancer Instit
World medicine November 23,2023
Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

In a recent study published in theNatureJournal, researchers described a new method to safely release deoxyribonucleic acid (DNA) trapped inside the ancient tooth and bone artifacts, which
Breakthroughs November 23,2023
Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

In a recent study published in theNatureJournal, researchers described a new method to safely release deoxyribonucleic acid (DNA) trapped inside the ancient tooth and bone artifacts, which
Breakthroughs November 23,2023
Tazemetostat Addition Aims to Bolster Efficacy of Lenalidomide Plus Rituximab in R/R Follicular Lymphoma

Tazemetostat Addition Aims to Bolster Efficacy of Lenalidomide Plus Rituximab in R/R Follicular Lymphoma

October 11, 2023Kyle DohertyAlthough relapsed/refractory follicular lymphoma remains a difficult- to-treat disease, the emergence of anti-CD20 monoclonal antibodies in recent years has signaled progre
World medicine November 23,2023
Tazemetostat Addition Aims to Bolster Efficacy of Lenalidomide Plus Rituximab in R/R Follicular Lymphoma

Tazemetostat Addition Aims to Bolster Efficacy of Lenalidomide Plus Rituximab in R/R Follicular Lymphoma

October 11, 2023Kyle DohertyAlthough relapsed/refractory follicular lymphoma remains a difficult- to-treat disease, the emergence of anti-CD20 monoclonal antibodies in recent years has signaled progre
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com